Liquid biopsy

Results presented at IASLC 2020 highlight the promising role of liquid biopsy in non-small cell lung carcinoma testing

Tapping into CSF and blood may overcome the challenges of diagnosing and monitoring brain tumors

What ctDNA and CTCs can tell us about the likelihood of breast cancer survival and recurrence

A new algorithm may help identify rare circulating tumor cells to improve liquid biopsy

Liquid biopsy is minimally invasive and easily accessible – but what information can a new multiplexed assay provide from circulating tumor DNA?

A new, biomarker-based test may allow sepsis diagnosis and intervention before patients become symptomatic

To improve cancer screening compliance, patients may benefit from sensitive, specific, noninvasive blood tests

A new combination of urine biomarkers could help avoid the 60 percent of unnecessary biopsies for prostate cancer

A new microfluidic chip analyzes urine samples to detect prostate cancer cells.

New ctDNA biomarkers could lead to more informed treatment decisions for patients with advanced non-small cell lung cancer and pediatric osteosarcoma